Galapagos NV
GLPG
$29.22
Share price
-0.92%
Change (1 day)
-23.31%
Change (1 year)
Categories
Galapagos NV (GLPG) - Total debt
Total debt on the balance sheet as of September 2023 : $14.94 M
According to Galapagos NV's latest financial reports the company's total debt is $14.94 M. A company’s total debt is the sum of all current and non-current debts.
Galapagos NV - Total debt on balance sheet (from 2008 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $23.45 M | -22.89% |
| 2021-12-31 | $30.41 M | -15.99% |
| 2020-12-31 | $36.2 M | 27.32% |
| 2019-12-31 | $28.43 M | |
| 2018-12-31 | $N/A | -100% |
| 2017-12-31 | $0.01 M | -83.71% |
| 2016-12-31 | $0.06 M | -47.26% |
| 2015-12-31 | $0.12 M | -38.09% |
| 2014-12-31 | $0.2 M | -62.58% |
| 2013-12-31 | $0.54 M | 1.31% |
| 2012-12-31 | $0.53 M | -52.81% |
| 2011-12-31 | $1.13 M | -31.44% |
| 2010-12-31 | $1.65 M | -22.11% |
| 2009-12-31 | $2.12 M | -9.8% |
| 2008-12-31 | $2.35 M | -63.04% |
| 2007-12-31 | $6.37 M | -37.88% |
| 2006-12-31 | $10.26 M | 9.06% |
| 2005-12-31 | $9.41 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $29.33 B | 196,145.30% | 🇺🇸 USA |
 Abbott Laboratories ABT | $15.62 B | 104,458.90% | 🇺🇸 USA |
 AbbVie ABBV | $59.38 B | 397,214.44% | 🇺🇸 USA |
 Sanofi SNY | $20.36 B | 136,165.77% | 🇫🇷 France |
 Merck MRK | $35.05 B | 234,434.94% | 🇺🇸 USA |
 AstraZeneca AZN | $28.62 B | 191,395.06% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $22.93 B | 153,358.98% | 🇬🇧 UK |
 Fortress Biotech
FBIO | $70.14 M | 369.32% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $20.15 B | 134,733.34% | 🇮🇱 Israel |